Global Healthcare Deal Activity Accelerates
Global healthcare deal activity is entering a new expansion cycle, with biopharma, medtech, and healthcare services companies accelerating mergers, acquisitions, and strategic partnerships. After a cautious 2023–2024 environment shaped by macroeconomic volatility and regulatory uncertainty, 2025 marked a turning point as capital markets stabilized and large players resumed portfolio realignment. The early months of 2026 … Read more